期刊文献+

上皮间质转化相关的生物标志在胃癌中的研究进展 被引量:8

Biomarkers of epithelialmesenchymal transition in gastric cancer
下载PDF
导出
摘要 转移是胃癌的主要死因.研究胃癌的转移机制,能为未来发展治疗胃癌的新手段提供必要的理论基础.上皮间质转化是上皮细胞转化成间充质样细胞并伴随明显基因和表型改变的一种多阶段过程,这种转化亦可在肿瘤细胞中发生,其会赋予肿瘤细胞侵袭和转移能力,使其更易形成远处转移灶,故上皮间质转化是肿瘤发生转移的重要机制之一.本文综述了近年来上皮间质转化的相关生物标志物,包括细胞表面蛋白(E-cadherin、N-cadherin)、细胞骨架蛋白(-catenin、Vimentin)、转录因子(Snail、Twist、ZEB1、ZEB2)等在胃癌中的研究进展. In gastric cancer, metastases are the major cause of death. Understanding the mechanism by which tumor cells invade and metastasize is essential to develop novel treatments for gastric cancer (GC). Epithelial-mesenchymal transition (EMT) is a multistage process in which epithelial cells develop into mesenchymal-like cells with a large number of distinct genetic and epigenetic alterations. EMT also occurs in cancer, which endows invasive and metastatic properties upon cancer cells that favor successful colonization of distal target organs. Here, we summarize studies of known EMT biomarkers in the context of GC progression. The biomarkers discussed include cell-surface proteins (E-cadherin and N-cadherin), cytoskeletal proteins (β-catenin and Vimentin), and transcription factors (Snail, Twist, ZEB1 and ZEB2).
出处 《世界华人消化杂志》 CAS 北大核心 2013年第30期3204-3210,共7页 World Chinese Journal of Digestology
基金 福建省2012年临床医学重点专科基金资助项目 No.闽卫科教[2012]149号 福建省财政厅专项基金资助项目 No.2012B013~~
关键词 上皮间质转化 生物标记 肿瘤转移 胃癌 Epithelial-mesenchymal transition Biological markers Neoplasm metastases Stomach neoplasms
  • 相关文献

参考文献1

二级参考文献1

共引文献4

同被引文献84

  • 1Lauren分类:弥漫型、肠型、混合型和不明型(WHO胃癌分类)第4版.2010:53. 被引量:1
  • 2Rosado JO, Henriques JP, Bonatto D. A systems pharmacology analysis of major chemotherapy combination regimens used in gas- tric cancer treatment: predicting potential new protein targets and drugs. Curr Cancer Drug Targets, 2011,11(7):849-869. 被引量:1
  • 3Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, Hu MY, Xu Y, Song ZJ, Wang ZJ, Wu JC, Bai DS, Li JC, Liu KD, Fan J. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 2009; 49: 491-503. 被引量:1
  • 4Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, Wang XY, Devbhandari RP, Fan J. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology 2011; 140: 1629-1641.e15. 被引量:1
  • 5Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-196. 被引量:1
  • 6Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010; 15: 117-134. 被引量:1
  • 7Palmer TD, Martínez CH, Vasquez C, Hebron KE, Jones-Paris C, Arnold SA, Chan SM, Chalasani V, Gomez-Lemus JA, Williams AK, Chin JL, Giannico GA, Ketova T, Lewis JD, Zijlstra A. Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Cancer Res 2014; 74: 173-187. 被引量:1
  • 8Kwon MJ, Seo J, Kim YJ, Kwon MJ, Choi JY, Kim TE, Lee DH, Park S, Shin YK, Han J, Choi YL. Prognostic significance of CD151 overexpression in non-small cell lung cancer. Lung Cancer 2013; 81: 109-116. 被引量:1
  • 9Ha SY, Do IG, Lee J, Park SH, Park JO, Kang WK, Choi MG, Lee JH, Bae JM, Kim S, Kim KM, Sohn TS. CD151 overexpression is associated with poor prognosis in patients with pT3 gastric cancer. Ann Surg Oncol 2014; 21: 1099-1106. 被引量:1
  • 10Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Kwon MJ, Nam SJ, Im YH, Shin YK, Choi YL. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer 2012; 106: 923-930. 被引量:1

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部